Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Electrolyte anion adverse reaction |
Causative agent |
False |
elektrolytanionmiddel |
Inferred relationship |
Some |
|
allergi over for væske eller opløsning indeholdende elektrolytanion |
Causative agent |
False |
elektrolytanionmiddel |
Inferred relationship |
Some |
|
phosphatforbindelse 16,1 mmol brusetablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
elektrolytanionmiddel |
Inferred relationship |
Some |
|
elektrolytanionprodukt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
elektrolytanionmiddel |
Inferred relationship |
Some |
|
phosphatprodukt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
elektrolytanionmiddel |
Inferred relationship |
Some |
|
Product containing sodium glycerophosphate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
elektrolytanionmiddel |
Inferred relationship |
Some |
|
natriumglycerophosphat 4,32 g injektionsvæske, opløsning, hætteglas a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
elektrolytanionmiddel |
Inferred relationship |
Some |
|
Minerals-phosphate supplements |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
elektrolytanionmiddel |
Inferred relationship |
Some |
|
Phosphate salts |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
elektrolytanionmiddel |
Inferred relationship |
Some |
|
allergi over for væske eller opløsning indeholdende elektrolytanion |
Causative agent |
False |
elektrolytanionmiddel |
Inferred relationship |
Some |
1 |